BNTX News and Press, BioNTech SE From 05/06/24

2024-05-06 11:08:32 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions BioNTech Q1 2024 Earn...

2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...

2024-05-06 07:03:49 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions BioNTech Q1 2024 Earnin...

PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....

Advancing toward goal of ten or more potentially registrational trials running by the end of 2024: first patient dosed in Phase 3 clinical trial evaluating BNT323/DB-1303 in HR+ HER2-low chemotherapy-naïve metastatic breast cancer patients, and a second Phase 3 trial with BNT323/DB-1303 in r...

2024-05-05 08:00:00 ET As Wall Street embarks on the first full week of May, a diverse group of companies is set to report financial results. Notable names include The Walt Disney Company ( NYSE: DIS ), Palantir Technologies ( NYSE: PLTR ), Realty Income ( NYSE: ...

2024-05-04 16:47:00 ET The healthcare sector had 24 companies reporting their quarterly earnings this week, with 16 of them beating their topline numbers for the quarter.... Read the full article on Seeking Alpha For further details see: 16 out of 24 health care companies be...

2024-05-03 12:53:06 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions Pfizer raises guidance ...

2024-05-03 09:31:56 ET Summary BioNTech is a biotech company with a strong cash position and a commercial program generating cash flow, making it a promising investment opportunity. The company's pipeline includes programs targeting cancer, respiratory infections, and other diseas...

2024-05-03 09:25:51 ET Summary BioNTech is expected to report a significant decline in sales for the first quarter, mainly due to the decline in COVID vaccine revenues. The company's earnings per share is also expected to be worse compared to the previous year. Investors shoul...